RT @StockExpert3: $WIN Down -50% https://t.co/oNAUMXqjxG Was 3$+ 5 Days ago 45 Cents Now May Bounce $VALE $GOLD $CZR $FOXA $EWZ $ACW $VIPS…
I need help, if anyone know some editorship/chatroom, that can teach me trading big caps, let me know. If has to ex… https://t.co/UffaTs1S51
$pfe
Wowza https://t.co/hjf9P5TKS6
Largest $Notional Sell On Close Order Imbalances $BAC $HUM $PXD $PFE $HCA $MCK $CI $HPQ $DHI $LMT https://t.co/V7Aciy2vFa
$AIG, $TWTR, $BAC, $ATEC, $PFE, $WFC hit new breakout highs https://t.co/qwCj3iCBfg
$BAC $HUM $PXD $PFE $HCA $MCK $CI $HPQ $DHI $LMT $WH $AME $LLY $T $DPZ $WLK $OKE $C $HD $KR $BSX $BAX Largest MOC S… https://t.co/dDoI7oW2oK
RT @JohnCendpts: Sorry -- here's the right link to the $PFE story on Xeljanz warning -- could be bad news for the entire JAK inhibitor clas…
RT @JohnCendpts: Sorry -- here's the right link to the $PFE story on Xeljanz warning -- could be bad news for the entire JAK inhibitor clas…
RT @JohnCendpts: Sorry -- here's the right link to the $PFE story on Xeljanz warning -- could be bad news for the entire JAK inhibitor clas…
RT @JohnCendpts: Sorry -- here's the right link to the $PFE story on Xeljanz warning -- could be bad news for the entire JAK inhibitor clas…
RT @JohnCendpts: Sorry -- here's the right link to the $PFE story on Xeljanz warning -- could be bad news for the entire JAK inhibitor clas…
RT @JohnCendpts: Sorry -- here's the right link to the $PFE story on Xeljanz warning -- could be bad news for the entire JAK inhibitor clas…
RT @JohnCendpts: Sorry -- here's the right link to the $PFE story on Xeljanz warning -- could be bad news for the entire JAK inhibitor clas…
Sorry -- here's the right link to the $PFE story on Xeljanz warning -- could be bad news for the entire JAK inhibit… https://t.co/IDRXJZD2kn
@LTbioinvestor i think $pfe will buyout
$lly
@realwillmeade i think $pfe will buyout $lly
@acethemarkets looks like $pfe will buyout $lly
@EquityFeedAlert looks like $pfe will buyout $lly
UPDATED: FDA sounds the alarm on Pfizer’s blockbuster Xeljanz after a high dose was linked to a higher death rate,… https://t.co/dUczhthRE5
FDA responds to safety signal reported in required postmarketing trial for Xeljanz $PFE httpswww.prnewswire.comnews… https://t.co/Z63YB5Muvj
Pfizer Inc. (PFE) – Noteworthy Spotlight https://t.co/sB0q2S9QrV $PFE #stocks #stockmarket
RT @odibro: FDA responds to safety signal reported in required postmarketing trial for Xeljanz $PFE https://t.co/DynPRN1aSV
Uh oh $pfe https://t.co/lw3YWYxGMy
@odibro Is that normal? Press release by the FDA on safety issues? $PFE #Xeljanz
RT @odibro: FDA responds to safety signal reported in required postmarketing trial for Xeljanz $PFE https://t.co/DynPRN1aSV
RT @odibro: FDA responds to safety signal reported in required postmarketing trial for Xeljanz $PFE https://t.co/DynPRN1aSV
RT @odibro: FDA responds to safety signal reported in required postmarketing trial for Xeljanz $PFE https://t.co/DynPRN1aSV
FDA responds to safety signal reported in required postmarketing trial for Xeljanz $PFE https://t.co/DynPRN1aSV
I need help, if anyone know some mentors/chatroom, that can teach me trading big caps, let me know. If has to expla… https://t.co/n0pwzrwCrE
RT: Sorry -- here's the right link to the $PFE story on Xeljanz warning -- could be bad news for the entire JAK inh… https://t.co/r9xNWvs6d4
Top 20 reporters of goodwill as of 2/25/19. $T, $GE, $BRK, $BAC, $DWDP, $PFE, $UNH, $AGH, $JPM, ... Note: companies… https://t.co/2fWRDOQxuZ
RT @JohnCendpts: Sorry -- here's the right link to the $PFE story on Xeljanz warning -- could be bad news for the entire JAK inhibitor clas…
Drugmakers spend just a small portion of revenue on research and development, and innovation has slowed, so price g… https://t.co/PbfUgMnVGE
@JohnCendpts Don’t they have a oral jak inhibitor being studied for alopecia areta? Aclaris ar least ha s a topical… https://t.co/lPmfGUNCc4
RT @JohnCendpts: UPDATED: FDA sounds the alarm on Pfizer’s blockbuster Xeljanz after a high dose was linked to a higher death rate, blood c…
RT @JohnCendpts: Sorry -- here's the right link to the $PFE story on Xeljanz warning -- could be bad news for the entire JAK inhibitor clas…
Pfizer $PFE Technical Update https://t.co/DuJNap3eIY
RT @megtirrell: Tuesday’s drug price hearing will be deja vu all over again - not just from recent years but from six decades ago. Great re…
$PFE #Pfizer Pfizer Inc.: | https://t.co/W3DHykrtWe https://t.co/sZOUuYgbw3
RT @STL_Biotech: Recent review in Nature of Adeno-associated virus vectors for gene delivery. Useful for those following $ONCE takeout and…
RT @STL_Biotech: Recent review in Nature of Adeno-associated virus vectors for gene delivery. Useful for those following $ONCE takeout and…
Recent review in Nature of Adeno-associated virus vectors for gene delivery. Useful for those following $ONCE takeo… https://t.co/A46xahymWz
RT @JohnCendpts: UPDATED: FDA sounds the alarm on Pfizer’s blockbuster Xeljanz after a high dose was linked to a higher death rate, blood c…
https://t.co/QpzIZ68ulC review I’ve been a member of Jason Bond Picks for 2 years and made some serious profits! $GPRO $FIT $PFE
Well, maybe $ABBV, $AZN, $BMY $JNJ, $MRK, $PFE & $SNY will stun us all & simply say, "Sure, whatever you say" to… https://t.co/0iZyWGAWgI
RT @HedgeFundTips: (100% Recent Accuracy) Is Healthcare $XLV about to get Sick? https://t.co/C9btZ8n6mX $JNJ $UNH $PFE $MRK $ABT $MDT $ABBV…
UBS: Time To Buy Pfizer $PFE? Has $45 Valuation Target https://t.co/MDYMn5MoES
UBS Says That Pfizer $PFE Has $45 Stock Target https://t.co/conFzt4e6x
Should Pfizer $PFE Shares Be Watched After UBS Initiates Coverage? https://t.co/mjRyYp7zoA
RT @STL_Biotech: Recent review in Nature of Adeno-associated virus vectors for gene delivery. Useful for those following $ONCE takeout and…
@YoungChris27040 @JohnCendpts Maybe it would be a positive for $CNCE CTP-543, which is studying much lower JAK dosi… https://t.co/XTE2Qjo45a
RT @odibro: FDA responds to safety signal reported in required postmarketing trial for Xeljanz $PFE https://t.co/DynPRN1aSV
RT @STL_Biotech: Recent review in Nature of Adeno-associated virus vectors for gene delivery. Useful for those following $ONCE takeout and…
RT @arnabch01: #AI #ML #Iot #robotics to usher revolution in #oncology https://t.co/NL4M7MZSQT $GOOG $MSFT $IBM $JNJ $PFE $NVS $GSK $SNY $M…
RT @AndyBiotech: $PFE Xeljanz 10mg BID "statistically and clinically meaningful difference" in PE rate and increase in overall mortality. M…
RT @JohnCendpts: Sorry -- here's the right link to the $PFE story on Xeljanz warning -- could be bad news for the entire JAK inhibitor clas…
The pharmaceutical industry will reach $1170 billion in 2021. Here’s the best stock you can invest in [Click the l… https://t.co/QtvhK03cmg
RT @arnabch01: @MotorcycleTwitt @SpirosMargaris @nodexl @ipfconline1 @evankirstel @MikeQuindazzi @pmedina @enkronos @Ronald_vanLoon @simpli…
Active Runner in Focus – Pfizer Inc (PFE) Moves 0.07 https://t.co/3LNInXQVKp $PFE #stocks #stockmarket
RT @JohnCendpts: Sorry -- here's the right link to the $PFE story on Xeljanz warning -- could be bad news for the entire JAK inhibitor clas…
max money flow (price x volume traded) Monday - $AMZN $BABA $AAPL $GE $NFLX $FB $NVDA $MSFT $ONCE $TSLA $KHC $AMD… https://t.co/lhTrw5bLU4
RT @Tischendorf: $LLY Eli Lilly. Large-cap pharmaceutical company. Clean and simple monthly chart analysis with technical price target. $JN…
RT @JohnCendpts: Sorry -- here's the right link to the $PFE story on Xeljanz warning -- could be bad news for the entire JAK inhibitor clas…
RT @AndyBiotech: $PFE Xeljanz 10mg BID "statistically and clinically meaningful difference" in PE rate and increase in overall mortality. M…
RT @STL_Biotech: Recent review in Nature of Adeno-associated virus vectors for gene delivery. Useful for those following $ONCE takeout and…
RT @Bioinvestor71: $ATRS should have record earnings with XYOSTED, Epipen, Makena, Otrexup, and Sumatriptan … maybe more if $PFE gave money…
RT @BehaviorFin: If Roche's buy out of $ONCE is confirmed, which #genetherapy #geneediting will be next ?
$BLUE $QURE $RGNX $SGMO $CLLS $CR…
RT @BehaviorFin: If Roche's buy out of $ONCE is confirmed, which is the main reason: eye approved treatment, ongoing Hemo treatment, whole…
most active stocks Monday - $GE $AMD $NIO $KHC $BAC $SNAP $IQ $NOK $JD $F $GG $UNIT $ECA $MU $ROKU $BABA $VALE… https://t.co/4ksy8C5nWy
RT @portefeuillefun: @AndyBiotech The #filgotinib data look pretty solid in that respect (from this recent presentation -> https://t.co/1SU…
$PFE $JNJ $MRK - Day of reckoning for Big Pharma https://t.co/uW7KUrcgtA
$PFE SA published current article at February 26, 03:14:39: Day of reckoning for Big Pharma https://t.co/hG4CQZucno
#geneediting #genetherapy
Which company will be the LAST to be acquired?
for whichever reason.
$BMRN $BLUE $SRPT… https://t.co/vFynu0bZkx
has the decade of #geneediting #genetherapy started?
https://t.co/eyfEsMF1TC
$BMRN $BLUE $SRPT $NVS $AXVS $SGMO… https://t.co/fqP3TFseUE
new 30 day highs ranked by volume Monday - $GE $AMD $NIO $SNAP $IQ $JD $MU $BABA $UXIN $ROKU $FOXA $AAPL $ONCE… https://t.co/gH4gJrg8xm
All SS $ROKU $QURE $PFE and $TTNP https://t.co/2EEVz1EVE6
Day of reckoning for Big Pharma https://t.co/t3QOjGr8uV $PFE, $JNJ, $MRK, $ABBV, $AZN, $BMY, $SNY
$PFE $JNJ $MRK - Day of reckoning for Big Pharma https://t.co/jpihQSNvoF
on watch
$NEM $GG $KL $GOLD
$DRIP $UCO $USO $CHK
$ACB $HEXO
$VXXB $UVXY
$D $DUK $SO
$PYPL
$PFE
$NIO $TSLA
$MAT
As Bank Of America $BAC Share Value Declined, Holder Oakworth Capital Lowered by $4.29 Million Its Stake; As Pfizer… https://t.co/t7lFXc08HX
Daily Stock Pick: Pfizer Inc $PFE https://t.co/it065yJYSv
RT @JohnCendpts: Sorry -- here's the right link to the $PFE story on Xeljanz warning -- could be bad news for the entire JAK inhibitor clas…
Jnba Financial Advisors Boosted Stake in Pfizer INC $PFE https://t.co/wb7cFsOZK2
Trust Co Of Oklahoma Has Lowered Its Pfizer $PFE Stake by $70.51 Million; Shares Rose; Black Creek Investment Manag… https://t.co/v4xl7vH5WQ
RT @JohnCendpts: ICYMI --
UPDATED: FDA sounds the alarm on Pfizer’s blockbuster Xeljanz after a high dose was linked to a higher death rate…
Centurylink Investment Management Company Has Lowered Pfizer $PFE Position; American Mortgage Acceptance Co $AMC Ha… https://t.co/UtS5SJr0xX
As Hollyfrontier $HFC Share Value Declined, Holder Nuwave Investment Management Has Lowered Its Position; Nexus Inv… https://t.co/AuRdCx51M2
ICYMI --
UPDATED: FDA sounds the alarm on Pfizer’s blockbuster Xeljanz after a high dose was linked to a higher dea… https://t.co/cVpMEKGN5X
RT @JohnCendpts: Sorry -- here's the right link to the $PFE story on Xeljanz warning -- could be bad news for the entire JAK inhibitor clas…
RT @JohnCendpts: Sorry -- here's the right link to the $PFE story on Xeljanz warning -- could be bad news for the entire JAK inhibitor clas…
$ABBV $BMY $JNJ $MRK $PFE:
‘Wacky’ drug price system keeps costs high for patients paying for prescriptions, FD…:
https://t.co/rvYdaDSZEe
$ABBV $BMY $JNJ $MRK $PFE:
Sen. Grassley says probe of ‘secretive’ drug industry pricing won’t stop with drug…:
https://t.co/WY2wMmDrfP
@biotechchat @YoungChris27040 @JohnCendpts May be true, but I was responding to @YoungChris27040 who singled out… https://t.co/Ta8loJYMt2
$ABBV $AZN $BMY $MRK $PFE:
Capitol Report: Curtain rises on 3 days of Michael Cohen drama | Republican senator say… https://t.co/GE5gkEoux8
Cubic Asset Management Increases Position in Patterson Cos $PDCO; As Pfizer $PFE Market Valuation Rose, New England… https://t.co/i4AVkzB40n
RT @DrugChannels: Must watch TV! Today at 10:15 AM, @SenateFinance hearing on "Drug Pricing in America" with @abbvie $ABBV, @AstraZeneca $A…
Must watch TV! Today at 10:15 AM, @SenateFinance hearing on "Drug Pricing in America" with @abbvie $ABBV,… https://t.co/83xvmpZ3gS
CEO of $BMY $PFE $ABBV $AMGN $JNJ $ABT and other big pharmaceutical companies to testify before congress today https://t.co/vFGn3pTPMY
Greenleaf Trust Has Upped Stake in Pfizer $PFE; Gabelli Funds Has Trimmed Position in Berkley W R Com $WRB by $316,… https://t.co/7eq2CNIfDm
RT @JohnCendpts: ICYMI --
UPDATED: FDA sounds the alarm on Pfizer’s blockbuster Xeljanz after a high dose was linked to a higher death rate…